WO2022185599A1 - Agent de réduction de protéine carbonylée pour les cheveux - Google Patents
Agent de réduction de protéine carbonylée pour les cheveux Download PDFInfo
- Publication number
- WO2022185599A1 WO2022185599A1 PCT/JP2021/038092 JP2021038092W WO2022185599A1 WO 2022185599 A1 WO2022185599 A1 WO 2022185599A1 JP 2021038092 W JP2021038092 W JP 2021038092W WO 2022185599 A1 WO2022185599 A1 WO 2022185599A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair
- reducing agent
- hydrogen atom
- agent
- carbon atoms
- Prior art date
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 245
- 239000003638 chemical reducing agent Substances 0.000 title claims abstract description 75
- 108091006003 carbonylated proteins Proteins 0.000 title claims abstract description 45
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 64
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 40
- 239000003377 acid catalyst Substances 0.000 claims abstract description 32
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 32
- 238000006268 reductive amination reaction Methods 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 125000004432 carbon atom Chemical group C* 0.000 claims description 31
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 30
- 125000000217 alkyl group Chemical group 0.000 claims description 30
- 230000002829 reductive effect Effects 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000002904 solvent Substances 0.000 claims description 26
- 238000011282 treatment Methods 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 23
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 22
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 19
- 229930024421 Adenine Natural products 0.000 claims description 17
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 17
- 229960000643 adenine Drugs 0.000 claims description 17
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 15
- VPEPQDBAIMZCGV-UHFFFAOYSA-N boron;5-ethyl-2-methylpyridine Chemical compound [B].CCC1=CC=C(C)N=C1 VPEPQDBAIMZCGV-UHFFFAOYSA-N 0.000 claims description 15
- 150000001720 carbohydrates Chemical class 0.000 claims description 15
- 230000006315 carbonylation Effects 0.000 claims description 15
- 238000005810 carbonylation reaction Methods 0.000 claims description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 14
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 14
- 206010016807 Fluid retention Diseases 0.000 claims description 13
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 13
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 12
- 235000011054 acetic acid Nutrition 0.000 claims description 10
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 claims description 10
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- 229910019142 PO4 Inorganic materials 0.000 claims description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 9
- 239000010452 phosphate Substances 0.000 claims description 9
- -1 sodium triacetoxyborohydride Chemical compound 0.000 claims description 9
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 7
- 229960003966 nicotinamide Drugs 0.000 claims description 7
- 235000005152 nicotinamide Nutrition 0.000 claims description 7
- 239000011570 nicotinamide Substances 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 6
- 150000003863 ammonium salts Chemical class 0.000 claims description 6
- QHXLIQMGIGEHJP-UHFFFAOYSA-N picoline - borane complex Substances [B].CC1=CC=CC=N1 QHXLIQMGIGEHJP-UHFFFAOYSA-N 0.000 claims description 6
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 5
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 claims description 5
- 229910000085 borane Inorganic materials 0.000 claims description 5
- 235000015165 citric acid Nutrition 0.000 claims description 5
- 235000019253 formic acid Nutrition 0.000 claims description 5
- 230000004048 modification Effects 0.000 claims description 5
- 238000012986 modification Methods 0.000 claims description 5
- 235000006408 oxalic acid Nutrition 0.000 claims description 5
- 235000011007 phosphoric acid Nutrition 0.000 claims description 5
- 235000019260 propionic acid Nutrition 0.000 claims description 5
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 5
- 239000012321 sodium triacetoxyborohydride Substances 0.000 claims description 4
- 230000032683 aging Effects 0.000 abstract description 12
- 230000003648 hair appearance Effects 0.000 abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 238000012360 testing method Methods 0.000 description 15
- 230000001788 irregular Effects 0.000 description 14
- 235000014633 carbohydrates Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 231100000640 hair analysis Toxicity 0.000 description 10
- 125000003277 amino group Chemical group 0.000 description 9
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229910003460 diamond Inorganic materials 0.000 description 4
- 239000010432 diamond Substances 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 150000002772 monosaccharides Chemical class 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- MEUCHQDLZYLNQY-UHFFFAOYSA-N 5-(aminocarbamothioylamino)-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid Chemical compound OC(=O)C1=CC(NC(=S)NN)=CC=C1C1=C2C=CC(=O)C=C2OC2=CC(O)=CC=C21 MEUCHQDLZYLNQY-UHFFFAOYSA-N 0.000 description 3
- RDMBHRPODMXKHT-UHFFFAOYSA-N 7-(2-aminoethylamino)-n,n-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(NCCN)C2=NON=C12 RDMBHRPODMXKHT-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000003676 hair preparation Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001340526 Chrysoclista linneella Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 210000004919 hair shaft Anatomy 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 238000000879 optical micrograph Methods 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000003586 protic polar solvent Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical group C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000007848 Bronsted acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-RSVSWTKNSA-N D-altro-hexose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-RSVSWTKNSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- LGVFJHCENRNEOH-UHFFFAOYSA-N [O-]C(CC[N+]1(CCO)C=NCC1)=O Chemical compound [O-]C(CC[N+]1(CCO)C=NCC1)=O LGVFJHCENRNEOH-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- GZCGUPFRVQAUEE-ZXXMMSQZSA-N aldehydo-D-idose Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-ZXXMMSQZSA-N 0.000 description 1
- GZCGUPFRVQAUEE-KAZBKCHUSA-N aldehydo-D-talose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KAZBKCHUSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 229940075506 behentrimonium chloride Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 150000001768 cations Chemical group 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000003696 hair cross section Effects 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 230000003741 hair volume Effects 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- IRHWMYKYLWNHTL-UHFFFAOYSA-M sodium 2-(N-morpholino)ethanesulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCN1CCOCC1 IRHWMYKYLWNHTL-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Definitions
- the present invention relates to an agent, composition and method for reducing carbonylated protein in hair, which increases with age.
- Patent Document 1 discloses prevention or improvement of gray hair or senile alopecia containing at least one active ingredient selected from the group consisting of berberbine, derivatives thereof, and salts thereof. agents, agents for suppressing or improving DNA damage in hair follicle-constituting cells, and agents for suppressing decrease in melanocyte stem cells.
- Patent Document 2 discloses a peptide having an amino acid sequence of WY or a pharmaceutically acceptable salt or solvate thereof as an active ingredient.
- a composition for improving the appearance of hair comprising:
- an object of the present invention is to provide a new method and drug for improving age-related qualitative changes in hair.
- the present inventors focused on black and gray hair in people aged 40 and over and analyzed age-related qualitative changes in hair.
- the present inventors evaluated the degree of carbonylation, which is an index of aging, using white and black hair of women in each age group. As a result, the content of carbonylated proteins in hair increased with age, and there was a significant difference in carbonylation of white and black hair in women in their 50s and 60s compared to women in their 40s. .
- Non-Patent Documents 1 and 2 relate to correlations between carbonylated proteins of the stratum corneum and physiological parameters of the skin. These documents show that protein carbonylation is inversely proportional to the water content of the stratum corneum, and that carbonylation of keratin proteins in each layer reduces the water retention capacity. The inventors thought that hair keratin protein might also cause a similar phenomenon by being carbonylated in the same way as skin keratin protein.
- Non-Patent Document 3 reductive amination treatment with 5-ethyl-2-methylpyridine borane (PEMB) or Hantu ester can reduce carbonylated proteins in hair, which increases with age. showed that.
- PEMB 5-ethyl-2-methylpyridine borane
- Hantu ester can reduce carbonylated proteins in hair, which increases with age. showed that.
- Non-Patent Document 4 Non-Patent Document 4
- reductive amination treatment was possible for organic materials.
- the present inventors have shown for the first time that reductive amination treatment is also useful for organic materials.
- the present invention was made based on these findings.
- the present invention provides a carbonylated protein-reducing agent for hair containing a reductive aminating agent containing a reducing agent, an acid catalyst and a nitrogen source.
- the present invention also provides the agent for reducing carbonylated protein in hair, wherein the reducing agent is an organic borane complex or a compound represented by the following general formula (I).
- R 1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a carbohydrate having 1 to 16 carbon atoms, adenine dinucleotide or adenine dinucleotide phosphate
- R 2 and R 3 respectively each independently represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms
- R 4 and R 5 each independently represent a hydrogen atom, -COO-R 6 or -CO-NR 6 R 7 , Each 7 independently represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms.
- the present invention also provides that the reducing agent is 5-ethyl-2-methylpyridine borane (PEMB), 5-ethyl-2-methylpyridine borane complex, picoline borane complex, sodium cyanoborohydride (NaBH3CN) and trihydride.
- the hair carbonylated protein-reducing agent is provided, which is at least one selected from the group consisting of sodium acetoxyborate.
- the present invention also provides that the reducing agent is a compound represented by the general formula (I), R 1 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and at least one of R 4 and R 5 is - Provided is the hair carbonylated protein-reducing agent represented by COO-R 6 , where R 6 represents an alkyl group having 1 to 3 carbon atoms.
- the reducing agent is a compound represented by the general formula (I), R 1 represents a hydrogen atom, a carbohydrate having 1 to 16 carbon atoms, adenine dinucleotide or adenine dinucleotide phosphate, and R 4 represents a hydrogen atom, R 5 represents —CO—NR 6 R 7 , and R 6 and R 7 represent a hydrogen atom to provide the above carbonylated protein-reducing agent for hair.
- R 1 represents a hydrogen atom, a carbohydrate having 1 to 16 carbon atoms, adenine dinucleotide or adenine dinucleotide phosphate
- R 4 represents a hydrogen atom
- R 5 represents —CO—NR 6 R 7
- R 6 and R 7 represent a hydrogen atom to provide the above carbonylated protein-reducing agent for hair.
- the reducing agent is at least selected from the group consisting of reduced nicotinamide adenine dinucleotide phosphate (NADPH), reduced nicotinamide adenine dinucleotide (NADH), reduced nicotinamide and Hantu ester.
- NADPH reduced nicotinamide adenine dinucleotide phosphate
- NADH reduced nicotinamide adenine dinucleotide
- the present invention provides one of the above carbonylated protein-reducing agents for hair.
- the present invention also provides the hair carbonylation protein-reducing agent, wherein the acid catalyst is at least one selected from the group consisting of acetic acid, citric acid, formic acid, propionic acid, phosphoric acid and oxalic acid.
- the acid catalyst is at least one selected from the group consisting of acetic acid, citric acid, formic acid, propionic acid, phosphoric acid and oxalic acid.
- the present invention also provides the hair carbonylation protein-reducing agent, wherein the nitrogen source is ammonia or an ammonium salt.
- the present invention also provides a hair modification composition containing a reductive aminating agent containing a reducing agent, an acid catalyst and a nitrogen source, and a solvent.
- the present invention also provides the hair-modifying composition, wherein the reducing agent is an organic borane complex or a compound represented by the general formula (I).
- the present invention also provides that the reducing agent is 5-ethyl-2-methylpyridine borane (PEMB), 5-ethyl-2-methylpyridine borane complex, picoline borane complex, sodium cyanoborohydride (NaBH3CN) and trihydride.
- the above hair modification composition which is at least one selected from the group consisting of sodium acetoxyborate.
- the present invention also provides that the reducing agent is a compound represented by the general formula (I), R 1 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and at least one of R 4 and R 5 is - Provided is the above hair modifying composition, which represents COO-R 6 , where R 6 represents an alkyl group having 1 to 3 carbon atoms.
- the reducing agent is a compound represented by the general formula (I), wherein R 1 represents a carbohydrate having 1 to 16 carbon atoms, R 4 represents a hydrogen atom, and R 5 represents -CO- Provided is the above hair modifying composition, which represents NR 6 R 7 , wherein R 6 and R 7 represent hydrogen atoms.
- the reducing agent is at least selected from the group consisting of reduced nicotinamide adenine dinucleotide phosphate (NADPH), reduced nicotinamide adenine dinucleotide (NADH), reduced nicotinamide and Hantu ester.
- NADPH reduced nicotinamide adenine dinucleotide phosphate
- NADH reduced nicotinamide adenine dinucleotide
- Hantu ester is provided.
- the present invention also provides the hair modifying composition, wherein the acid catalyst is at least one selected from the group consisting of acetic acid, citric acid, formic acid, propionic acid, phosphoric acid and oxalic acid.
- the acid catalyst is at least one selected from the group consisting of acetic acid, citric acid, formic acid, propionic acid, phosphoric acid and oxalic acid.
- the present invention also provides the hair modifying composition, wherein the nitrogen source is ammonia or an ammonium salt.
- the present invention also provides the hair modifying composition, wherein the solvent is water or ethanol.
- the present invention also provides an agent for improving water retention of hair containing a reductive aminating agent containing a reducing agent, an acid catalyst and a nitrogen source.
- the present invention also provides a hair curvature reducing agent containing a reductive aminating agent comprising a reducing agent, an acid catalyst and a nitrogen source.
- the present invention also provides a method for reducing carbonylated proteins in hair, comprising reductively aminating hair with a reducing agent in a solvent in the presence of an acid catalyst and a nitrogen source.
- the present invention also provides a method for improving water retention of hair, comprising subjecting hair to reductive amination treatment with a reducing agent in a solvent in the presence of an acid catalyst and a nitrogen source.
- the present invention also provides a method for reducing the curvature of hair, comprising reductively aminating hair with a reducing agent in a solvent in the presence of an acid catalyst and a nitrogen source.
- the present invention can improve the water retention capacity of hair, which declines with aging.
- the present invention can reduce the curvature of hair, which increases with aging, and improve the irregular shape of hair. Therefore, the present invention can contribute to further improvement of quality of life (QOL).
- FIG. 1 shows measurement points for line mapping using optical microscopy images of untreated hair. Diagram showing the water behavior of black hair (diamond shape) and gray hair (triangle) in the cortex of a Japanese woman in her 50s. A diagram showing the localization of carbonylated proteins in cross sections of hair in each age group.
- FIG. 4 is a diagram showing the ratio of average fluorescence intensity in cross sections of white hair and black hair in each age group.
- FIG. 10 shows the average curvature of the hair of the same subject as in FIGS. 2 and 9.
- FIG. FIG. 3 shows the level of introduction of amino groups in reductive amination-treated hair.
- the present invention provides a carbonylated protein-reducing agent for hair containing a reductive aminating agent containing a reducing agent, an acid catalyst and a nitrogen source.
- reducing carbonylated protein in hair means reducing the amount of carbonylated protein contained in hair.
- hair includes both the hair shaft that emerges from the scalp and the hair root that resides within the scalp.
- Reducing hair carbonylated proteins includes reducing carbonylated proteins in at least one of the hair cuticle, cortex and medulla.
- reducing carbonylated protein as used herein includes suppressing an increase in carbonylated protein.
- a carbonylated protein is a protein in which amino acids such as proline, arginine, lysine or threonine in the protein are oxidized by reactive oxygen species (ROS) and the like to become carbonyl derivatives.
- ROS reactive oxygen species
- the hair carbonylated protein-reducing agent of the present invention can modify hair through reduction of hair carbonylated protein. That is, the agent for reducing carbonylated protein in hair of the present invention can be used as a hair modifying agent.
- modifying the hair includes improving the water retention capacity of the hair, reducing the average curvature of the hair, improving the irregular shape of the hair and improving the appearance of the hair. and so on.
- reductive aminating agent refers to an agent capable of converting a carbonyl group of a carbonylated protein into an amino group by a reductive amination reaction.
- a reductive amination reaction is a chemical reaction that converts an aldehyde or ketone to an amine.
- a reductive aminating agent is a mixture comprising a reducing agent, an acid catalyst and a nitrogen source.
- the reducing agent is used for the purpose of reducing the reaction intermediate imine to an amine.
- a reducing agent for example, an organic borane complex can be used.
- Organoborane complexes include, for example, 5-ethyl-2-methylpyridine borane (PEMB), 5-ethyl-2-methylpyridine borane complex, picoline borane complex, sodium cyanoborohydride (NaBH3CN) and sodium triacetoxyborohydride and so on. From the viewpoint of toxicity and safety, 5-ethyl-2-methylpyridine borane complex can be preferably used.
- a compound having a 1,4-dihydropyridine structure represented by the following general formula (I) can be used as the reducing agent in the present invention.
- R 1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or a carbohydrate having 1 to 16 carbon atoms.
- Alkyl groups represented by R 1 can be, for example, methyl, ethyl, propyl, isopropyl and cyclopropyl groups.
- R 2 and R 3 each independently represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms.
- R2 and R3 may be the same or different.
- Alkyl groups represented by R 2 and R 3 can be, for example, methyl, ethyl, propyl, isopropyl and cyclopropyl groups.
- R 4 and R 5 each independently represent a hydrogen atom, --COO--R 6 or --CO--NR 6 R 7 .
- R4 and R5 may be the same or different.
- R 6 and R 7 each independently represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms.
- R6 and R7 may be the same or different.
- Alkyl groups represented by R 6 and R 7 can be, for example, methyl, ethyl, propyl, isopropyl and cyclopropyl groups.
- alkyl group includes linear or branched alkyl groups.
- Alkyl groups include, for example, methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, neopentyl and hexyl groups. .
- Carbohydrate includes monosaccharides, disaccharides, oligosaccharides, amino sugars, alditols, and the like.
- Monosaccharides can be pyranosides or furanosides.
- Carbohydrates can be, for example, D-glucose, D-mannose, D-galactose, D-allose, D-altrose, D-idose, D-talose, D-xylose, D-ribose and D-arabinose.
- Carbohydrates may also have a structure in which two or more monosaccharides are linked by 1 to 3 phosphate groups.
- a monosaccharide constituting a carbohydrate may be, for example, a nucleoside or a nucleotide in which ribose and a nucleobase are linked.
- the carbohydrate can be, for example, adenine dinucleotide or adenine dinucleotide phosphate.
- alkyl groups and carbohydrates may have substituents.
- Substituents include, for example, halogen atoms, nitrogen atoms, sulfur atoms, hydroxyl groups, nitro groups, cyano groups, methoxy groups, ethoxy groups, carboxyl groups, carboxymethyl groups, carboxyethyl groups, methylenedioxy and the like.
- Halogen atoms include fluorine, chlorine, bromine, iodine, and the like.
- R 1 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms
- at least one of R 4 and R 5 represents —COO—R 6
- R 6 represents 1 to 3 carbon atoms.
- the reducing agent in the present invention is preferably Hantu ester represented by the following formula (II).
- R 1 represents a hydrogen atom or a carbohydrate having 1 to 16 carbon atoms
- R 4 represents a hydrogen atom
- R 5 represents —CO—NR 6 R 7
- R 6 and R 7 represents a hydrogen atom.
- R 1 represents a hydrogen atom, adenine dinucleotide or adenine dinucleotide phosphate
- R 2 , R 3 and R 4 represent a hydrogen atom
- R 5 represents —CO—NR 6 R 7 and R 6 and R7 each represent a hydrogen atom.
- the reducing agent in the present invention is, for example, reduced nicotinamide adenine dinucleotide phosphate (NADPH), reduced nicotinamide adenine dinucleotide (NADH) or reduced nicotinamide.
- NADPH/NADH are compounds having the structures shown below. A compound obtained by removing only the active site of NADH/NADPH is reduced niacinamide, both of which are biomolecules.
- Hantu ester is preferably used as the reducing agent of the present invention from the viewpoint of economy and stability. Hantuester can be purchased in large quantities at low cost and is easy to store.
- the compound represented by general formula (I) is used as a reducing agent in a reduced state. This compound functions as a reducing agent by releasing two electrons and becoming oxidized.
- the compound represented by the general formula (I) as the reducing agent of the present invention, it is possible to reduce the burden on the environment and increase the safety to the human body. Moreover, since water, ethanol, or the like can be used as a solvent, safety to the human body can be further enhanced.
- the compound of general formula (I) can be synthesized by any synthetic procedure known to those skilled in the art.
- PEMB 5-ethyl-2-methylpyridine borane
- PMB 5-ethyl-2-methylpyridine borane complex
- picoline borane complex sodium cyanoborohydride (NaBH3CN) and sodium triacetoxyborohydride
- reduced nicotine Commercially available compounds can be used for compounds such as amide adenine dinucleotide phosphate (NADPH), reduced nicotinamide adenine dinucleotide (NADH), reduced nicotinamide and Hantu ester.
- NADPH amide adenine dinucleotide phosphate
- NADH reduced nicotinamide adenine dinucleotide
- Hantu ester any reduced compound can be obtained by reducing an oxidized compound by a general procedure.
- an acid catalyst is an acid used for the purpose of protonating and activating a carbonyl group.
- the acid catalyst is not particularly limited as long as it is a Bronsted acid, and for example, acetic acid, citric acid, formic acid, propionic acid, phosphoric acid and oxalic acid can be used. From the viewpoint of safety and convenience, acetic acid or phosphoric acid can be preferably used, although it is not particularly limited.
- a nitrogen source is used to convert a carbonyl group into an imine.
- a nitrogen source although not particularly limited, for example, ammonia or an ammonium salt can be used.
- Ammonia and ammonium salts can restore carbonylated amino acids to their original amino acid structure.
- Specific examples of nitrogen sources that can be used include aqueous ammonia, ammonium formate, ammonium acetate, ammonium carbonate, and ammonium hydrogen carbonate. Although it is not particularly limited from the viewpoint of ease of operation, ammonia water or ammonium acetate can be preferably used.
- the present invention also provides a hair modification composition containing a reductive aminating agent containing a reducing agent, an acid catalyst and a nitrogen source, and a solvent.
- the solvent used in the present invention includes, but is not particularly limited to, protic solvents, aprotic polar solvents and aprotic solvents.
- Protic solvents include, for example, water, methanol, ethanol, 1-propanol, 2-propanol, propylene glycol, glycerin, butylene glycol and 1,3-BG.
- Aprotic polar solvents include, for example, dimethylsulfoxide, dimethylformamide, acetonitrile, hexamethylphosphoramide, and the like.
- Aprotic solvents include, for example, diethyl ether, chloroform, toluene, 1,4-dioxane and liquid hydrocarbons.
- water, methanol, or ethanol can be preferably used in terms of reactivity and ease of handling.
- water or ethanol can be preferably used.
- the present invention also provides a method for reducing carbonylated proteins in hair, comprising reductively aminating hair with a reducing agent in a solvent in the presence of an acid catalyst and a nitrogen source.
- hair can be treated with the agent or composition of the present invention as described above.
- the reductive amination treatment of hair with a reducing agent involves preparing a composition containing a nitrogen source such as an aqueous ammonia solution and a reducing agent in a solvent containing an acid catalyst.
- a method of treating the hair by, for example, can be used.
- the present invention also provides an agent for improving water retention of hair containing a reductive aminating agent containing a reducing agent, an acid catalyst and a nitrogen source.
- the present invention also provides a method of improving water retention of hair comprising reductively aminating hair with a reducing agent in a solvent in the presence of an acid catalyst and a nitrogen source.
- improving the water holding capacity of hair means improving the water holding capacity of hair that has decreased due to aging. Including suppressing a decrease in water retention capacity.
- the present invention also provides a hair curvature reducing agent containing a reductive aminating agent comprising a reducing agent, an acid catalyst and a nitrogen source.
- the present invention also provides a method of reducing the curvature of hair comprising reductively aminating hair with a reducing agent in a solvent in the presence of an acid catalyst and a nitrogen source.
- reducing the curvature of hair includes reducing the curvature of hair that has increased with age and suppressing the increase in curvature of hair with age.
- the “curvature of hair” represents the degree of disorder of hair, and the higher the curvature, the greater the degree of disorder of hair.
- agents and compositions of the present invention can contain any other ingredients in addition to the above-described ingredients, depending on the purpose of use, as long as they do not impair the effects of the present invention.
- the agents and compositions of the present invention include anionic surfactants such as lauryl sulfate, polyoxyethylene lauryluther sulfate, laurylbenzenesulfonate and sodium lauroylmeth- ⁇ -alanine;
- Amphoteric surfactants such as carboxymethyl-N-hydroxyethylimidazonium betaine, coconut fatty acid amidopropyl betaine and coconut alkyl N-carboxyethyl-N-hydroxyethylimidazolinium betaine sodium: cationized cellulose, polyacrylic acid and polymers such as poly(diallyldimethylammonium chloride); humectants such as sorbitol, inositol, glycerin, propylene glycol, butylene glycol
- agent and composition of the present invention can be in any form, such as liquid, milky lotion, cream, gel, paste and foam, depending on the purpose of use.
- the agents and compositions of the present invention can be in the form of hair cosmetics, for example.
- Hair cosmetics include, for example, hair rinses, hair conditioners, hair treatments, leave-in treatments, hair packs, hair foams, hair waxes, pomades, hair gels, hair creams, hair sprays, hair mists, hair waters, hair liquids, hair oils, Hair tonic, hair lotion, hair color, perming agent, hair tonic and the like are included.
- These hair cosmetics can be produced by conventionally known methods.
- Subjects were selected from healthy Japanese women aged 40-60 who had not dyed or permed their hair for one week prior to the test. Only shampoo was used on the day before the test, and no hair styling agent or hair treatment was used on the day of the test. Hair samples were soaked in deionized water for 10 minutes to remove temporary hair shapes and to assess the intrinsic shape of hair.
- Deuterium oxide 99.8% D was obtained from Kanto Kagaku Co., Ltd. (Tokyo, Japan).
- the average curvature of the hair was measured using the method described in Non-Patent Document 5. Specifically, the hair fibers were soaked in water at 25° C. for 10 minutes to remove the temporary water set formed during drying of the hair fibers and caused by the exchange of hydrogen bonds. Next, the hair fiber was set in an image scanner (GT-X830, manufactured by Seiko Epson Corporation), a two-dimensional image of the hair shape was acquired, and the curvature of each curve from the hair root to the hair tip was analyzed. Since hair color has little effect on hair shape, shape measurements were performed indiscriminately on color-treated hair.
- FIG. 3 shows an example of irregular shapes observed in white hair and dyed white hair.
- the water behavior evaluation was performed using a method applying the water permeation measurement method described in Patent Document 3. Specifically, we sandwiched a smooth hair section using a rotating microtome between diamond cells developed in-house, and injected heavy water into the cell gap. The hair sections were evaluated serially using a Fourier transform infrared microscope (Thermo Fisher Scientific, Nicolet iN10). Water behavior was visualized and quantified by evaluating the OD stretching peak intensity at ⁇ 2500 cm ⁇ 1 indicative of heavy water in real time by line mapping measurements every 10 ⁇ m from the medulla to the cuticle.
- FIG. 4 is a diagram showing measurement points for line mapping using an optical microscope image of untreated hair. In the measurement, the resolution was 8 cm -1 , the number of accumulations was 256, and the spectrum was obtained in the wavenumber range of 4000 to 650 cm -1 .
- Figure 5 shows the behavior of black hair (diamond-shaped) and white hair (triangle) in the cortex from the same person of a Japanese woman in her 50s (OD stretching peak intensity at ⁇ 2500 cm -1 ; , followed by a drying step at 25°C and 50% RH for 4 hours).
- This result indicates that white hair has a faster permeation rate of water from the outside than black hair.
- white hair lost moisture one hour earlier than black hair.
- the hair sample was immersed in 20 ⁇ M 5-FTSC/0.1 M MES-Na (pH 5.5) and incubated in the dark for 1 hour. After that, the hair was washed with PBS four times and observed under a fluorescence microscope. The resulting images were analyzed using ImageJ, and the fluorescence intensity per unit area of the hair sample was set as the degree of carbonylation.
- Figure 6 shows the localization of carbonylated proteins in hair cross sections of each age group ((a) black hair in the 40s; (b) black hair in the 50s; (c) black hair in the 60s; (e) White hair in the 50's (f) Gray hair in the 60's As shown in Figure 6, an increase in carbonylated protein was observed with age, and white hair has more carbonylated protein than black hair. It has been shown.
- FIG. 8 shows the localization of carbonylated proteins in a hair section of a Japanese woman in her 50s (Reagent: reductive amination treatment). Reductive amination treatment has been shown to reduce the amount of carbonylated proteins regardless of whether the hair is dark or white.
- Figure 9 shows the water behavior of black hair (diamond shape), white hair (triangle) and reductively aminated gray hair (square) from the same person in the fifties Japanese woman in the cortex (at ⁇ 2500 cm -1 ). OD stretching peak strength; first 30 minutes under heavy water penetration conditions, then drying process at 25°C, 50% RH for 4 hours). The white hair treated with reductive amination had improved water retention capacity and showed water behavior equivalent to that of black hair.
- 90% RH the mean curvature of 50's hair that had undergone reductive amination treatment was significantly reduced compared to hair that had not undergone reductive amination treatment.
- FIG. 11 shows the level of introduction of amino groups in reductively aminated hair. As shown in Figure 11, it was found that the hair treated with PEMB had a higher level of amino group incorporation and more DBD-ED was introduced into the hair compared to the absence of PEMB (control). rice field. This result indicated that amino groups were introduced into the hair by the PEMB treatment.
- FIG. 12 shows the effect of reducing carbonylated protein when using Hantu ester as a reducing agent.
- Hantuester reduction-treated hair showed reduced amounts of carbonylated proteins.
- FIG. 13 shows a comparison of the effect of reducing carbonylated protein by different solvents. The results showed that the amount of carbonylated proteins was reduced even in hair reduced using water or ethanol as a solvent.
- the present invention can be suitably used for cosmetics and pharmaceuticals for modifying hair.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Le problème décrit par la présente invention concerne le changement de qualité des cheveux dû au vieillissement qui est un problèmes particulièrement chez les femmes de plus de 40 ans. Si la qualité des cheveux peut être efficacement améliorée, la qualité de vie (QOL) peut être davantage améliorée. Le but de la présente invention est de fournir un nouveau procédé et un nouvel agent permettant tous deux d'améliorer le changement de qualité des cheveux avec l'âge. La solution selon l'invention porte sur un agent de réduction des protéines carbonylées pour les cheveux, un agent d'amélioration de la capacité de rétention d'eau pour les cheveux, et un agent de réduction de la courbure des cheveux, dont chacun comprend un agent de réduction, un catalyseur acide, et un agent d'amination réductrice contenant une source d'azote.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023503365A JPWO2022185599A1 (fr) | 2021-03-01 | 2021-10-14 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021-031412 | 2021-03-01 | ||
JP2021031412 | 2021-03-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022185599A1 true WO2022185599A1 (fr) | 2022-09-09 |
Family
ID=83154181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/038092 WO2022185599A1 (fr) | 2021-03-01 | 2021-10-14 | Agent de réduction de protéine carbonylée pour les cheveux |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2022185599A1 (fr) |
WO (1) | WO2022185599A1 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004284988A (ja) * | 2003-03-24 | 2004-10-14 | Kose Corp | 毛髪化粧料及び毛髪の蛋白質のカルボニル化を抑制する方法 |
JP2007291108A (ja) * | 2006-04-25 | 2007-11-08 | L'oreal Sa | ケラチン繊維の成長を誘導及び/又は刺激するため、並びに/あるいはそれらの損失を予防するための薬剤としての4−アミノピペリジン誘導体の使用 |
JP2008508262A (ja) * | 2004-07-30 | 2008-03-21 | コリア リサーチ インスティテュートオフ゛ ケミカル テクノロシ゛ー | 自己造形性パーマ剤と脱ロッド及び脱バンド型パーマ方法 |
JP2019001759A (ja) * | 2017-06-19 | 2019-01-10 | 株式会社ミルボン | 毛髪用組成物、及び毛髪処理方法 |
-
2021
- 2021-10-14 JP JP2023503365A patent/JPWO2022185599A1/ja active Pending
- 2021-10-14 WO PCT/JP2021/038092 patent/WO2022185599A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004284988A (ja) * | 2003-03-24 | 2004-10-14 | Kose Corp | 毛髪化粧料及び毛髪の蛋白質のカルボニル化を抑制する方法 |
JP2008508262A (ja) * | 2004-07-30 | 2008-03-21 | コリア リサーチ インスティテュートオフ゛ ケミカル テクノロシ゛ー | 自己造形性パーマ剤と脱ロッド及び脱バンド型パーマ方法 |
JP2007291108A (ja) * | 2006-04-25 | 2007-11-08 | L'oreal Sa | ケラチン繊維の成長を誘導及び/又は刺激するため、並びに/あるいはそれらの損失を予防するための薬剤としての4−アミノピペリジン誘導体の使用 |
JP2019001759A (ja) * | 2017-06-19 | 2019-01-10 | 株式会社ミルボン | 毛髪用組成物、及び毛髪処理方法 |
Non-Patent Citations (2)
Title |
---|
CHIKA WAKITA ET AL.: "Proteomic analysis of protein carbonyls using reductive amination reaction", ANNUAL MEETING OF JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY AND AGROCHEMISTRY; MARCH 27-29, 2009, 5 March 2009 (2009-03-05) - 29 March 2009 (2009-03-29), pages 57, XP009539585 * |
DATABASE GNPD MINTEL; December 2019 (2019-12-01), "XC-Hair Growth Serum", XP055963904, Database accession no. 7130589 * |
Also Published As
Publication number | Publication date |
---|---|
JPWO2022185599A1 (fr) | 2022-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2956117B1 (fr) | Composition cosmétique produisant un effet de pigmentation du cheveu | |
EP2119428B1 (fr) | Utilisation et procédé destiné à la réduction des cheveux frisés | |
US20080279804A1 (en) | Hair styling formulation and method of use | |
RU2768471C2 (ru) | Химическая композиция | |
US11883519B2 (en) | Cosmetic compositions and methods of use | |
EP3714866B1 (fr) | Procédé de traitement capillaire | |
EP1901064B1 (fr) | Procédé de mesure d'absorbabilité cutanée | |
WO2022185599A1 (fr) | Agent de réduction de protéine carbonylée pour les cheveux | |
US20190110968A1 (en) | Synephrine Compositions | |
CN110354021B (zh) | 阳离子聚合物在预洗发调理组合物中的应用 | |
US20030082132A1 (en) | Perming compositions and perming method by using the same | |
WO2019032805A1 (fr) | Compositions de traitement capillaire et procédés associés | |
KR102212894B1 (ko) | 호두 펩타이드를 유효성분으로 함유하는 모발 볼륨감 강화용 화장료 조성물 | |
JP2002071682A (ja) | 経毛吸収定量法 | |
US11351100B2 (en) | Hair coloring agent composition | |
KR101721939B1 (ko) | 글루타치온을 포함하는 펌제 조성물, 및 이를 구비하는 펌제 세트 | |
JP4113251B2 (ja) | 経毛吸収定量方法 | |
KR20110123452A (ko) | 지렁이 분해물을 함유하는 모발 보호 및 수복용 모발 화장품 조성물 | |
JP7489597B2 (ja) | 毛髪化粧料 | |
JP2024075103A (ja) | 毛髪の反復延伸による曲率増加の抑制剤 | |
JP2686696B2 (ja) | 染毛剤 | |
Trüeb et al. | Hair care and cosmetics | |
WO2023111076A1 (fr) | Composition cosmétique pour la restructuration de cheveux et l'amélioration de leur aspect | |
AU2022410322A1 (en) | Cosmetic composition for restructuring hair and improving the appearance thereof | |
JPH05294812A (ja) | 毛髪処理剤組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21929160 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2023503365 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21929160 Country of ref document: EP Kind code of ref document: A1 |